China Pacific Insurance reported stable insurance service revenue of RMB 218 billion in the first three quarters of 2026, a slight 0.1% increase year-on-year. Operating profit rose 5.6% to RMB 30 billion, driven by better property insurance underwriting and increased amortization of the contractual service margin. However, net profit declined 20.3% to RMB 36.4 billion, impacted by short-term capital market volatility. The company continues to focus on high-quality growth and asset-liability management amid macroeconomic challenges.
China Pacific Insurance's Q3 2026 earnings provide context for readers. For those tracking Financials, here is Pluang's market snapshot: of 142 priced Financials-sector US stocks tradable on Pluang, 66 rose and 73 fell today. Notable movers include BSBR at USD 4.68 with a -3.31% change, NU at USD 12.02 with a -3.06% change, and SLDE at USD 27.54 with a -2.99% change, as of Oct 28, 2026 21:21 WIB.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
